ShaoPuAiSi: Received an inquiry letter from the Shanghai Stock Exchange regarding the proposed acquisition of 100% equity of Shanghai Qinli for 528 million yuan.

robot
Abstract generation in progress

Recently, Saplus announced that it plans to acquire 100% equity of Shanghai Qinli held by Yihe Medical and Yanghe Industrial for 528 million yuan in cash. After the completion of this acquisition, Saplus will directly hold all shares of Shanghai Qinli and indirectly own 100% of Shanghai Tianlun Hospital.

This transaction constitutes a related-party transaction, with the counterparties being the company’s controlling shareholder Yanghe Industrial and its concerted party Yihe Medical. Prior to the transaction, the company did not hold any equity in Shanghai Qinli. After the acquisition, it will directly hold 100% of its shares and indirectly own 100% of its wholly owned subsidiary, Tianlun Hospital. The deal includes performance commitment clauses, with the target company promising net profits of no less than 32.4 million yuan, 37.3 million yuan, and 42.65 million yuan for 2026 to 2028, respectively, totaling a net profit of at least 112 million yuan.

On the same day, Saplus disclosed that it received an inquiry letter from the Shanghai Stock Exchange regarding this matter. The inquiry letter requests Saplus to disclose the reasonableness and fairness of the transaction valuation, the achievability of the performance commitments, the sources of funds and payment ability, the ownership, operational qualifications of the target assets, and transitional arrangements. Saplus is required to respond in writing within five trading days to these questions.

(Saplus Announcement)

(Edited by: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments